Hany Zayed
@endovascularu
Consultant Vascular Surgeon. views are my own. RT is not endorsement
ID: 1170266439154094080
07-09-2019 09:24:05
281 Tweet
847 Followers
557 Following
Hany Zayed shares final results from the PROMISE UK trial, including an amputation-free survival rate of 67% CX Symposium #CX2024
EJVES isabelle vanherzeele Hany Zayed Konstantinos Stavroulakis This was yet another collaboration across Europe 🌍 delivered by RCPAD - see details about our group on rcpad.org & feel free to send suggestions for #PAD projects if you wish to expand your research internationally 👇🏻
Really honored to have been part of the 10th Anniversary of the STARS conference in London. Great extreme BTK revascularization session. Many thanks Hany Zayed for your kind invitation! 🤗
Hany Zayed Congratulations Hany and team for their 10 yr anniversary of their highly commendable conference. Wish you all the more successful years ahead
Food for thought: in the last 15 years (or so), 5 or so NHS hospitals have recruited almost all UK participants in the completed/ongoing large National Institute for Health and Care Research British Heart Foundation vascular trials, 1/2
Don't miss this latest #EJVESOA "COST anaLYsis of Target Lesion Revascularization (TLR) in patients with femoropopliteal in-stent-restenosis or occlusion: the COSTLY-TLR study" Athanasios Saratzis isabelle vanherzeele Hany Zayed Mario D'Oria, MD Konstantinos Stavroulakis doi.org/10.1016/j.ejvs…
Athanasios Saratzis isabelle vanherzeele Hany Zayed Mario D'Oria, MD Konstantinos Stavroulakis We all want to avoid TLR, but at what cost, and what factors drive it? Maybe more expensive primary technology is appropriate, if TLR can be avoided? Including 482 TLR procedures, from 13 hospitals and 6 countries! Read the full article to find out more! doi.org/10.1016/j.ejvs…